Zimmer Biomet's (ZBH) strategic product launches and stabilizing market trends bolster our confidence in this stock. However, factors like macroeconomic uncertainties put pressure on the bottom line. The stock carries a Zacks Rank #3 (Hold).Zimmer Biomet has been witnessing strong market share gains within the reconstructive Knees and Hips businesses in key geographies despite macroeconomic challenges. According to the company, procedure growth continues successfully, aided by no meaningful impact from staf ...